Verrica Pharmaceuticals Inc
VRCA6.910USD
+0.300+4.54%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
65.58MValor de mercado
PerdaP/L TTM
Mais detalhes de Verrica Pharmaceuticals Inc Empresa
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing and selling medications for skin diseases requiring medical intervention. The Company's product portfolio consists of one approved product with several potential follow-on indications, as well as an additional pipeline product. Its commercial product, YCANTH (VP-102), is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. YCANTH (VP-102) is being developed for the treatment of molluscum contagiosum in adult and pediatric patients two years of age and older. It is also engaged in developing YCANTH (VP-102) for a potential follow-on indication for the treatment of common warts. Its second development candidate, VP-315, is an oncolytic peptide-based injectable therapy for the potential treatment of dermatology oncologic conditions, including basal cell carcinoma (BCC).
Informações de Verrica Pharmaceuticals Inc
Código da empresaVRCA
Nome da EmpresaVerrica Pharmaceuticals Inc
Data de listagemJun 15, 2018
CEORieger (Jayson)
Número de funcionários71
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 15
Endereço44 West Gay Street
CidadeWEST CHESTER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19380
Telefone14844533300
Sitehttps://verrica.com/
Código da empresaVRCA
Data de listagemJun 15, 2018
CEORieger (Jayson)
Executivos da empresa Verrica Pharmaceuticals Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jayson Rieger
Dr. Jayson Rieger
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
183.30K
+94311.00%
Mr. David Zawitz
Mr. David Zawitz
Chief Operating Officer
Chief Operating Officer
21.00K
+10000.00%
Dr. Noah L. Rosenberg, M.D.
Dr. Noah L. Rosenberg, M.D.
Chief Medical Officer
Chief Medical Officer
2.36K
+2357.00%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Independent Director
Independent Director
10.00
--
Dr. Gavin Corcoran
Dr. Gavin Corcoran
Independent Director
Independent Director
2.00
--
Mr. Paul B. Manning
Mr. Paul B. Manning
Chairman of the Board
Chairman of the Board
--
--
Mr. Mark A. Prygocki, Sr.
Mr. Mark A. Prygocki, Sr.
Independent Director
Independent Director
--
--
Dr. Lawrence Eichenfield, M.D.
Dr. Lawrence Eichenfield, M.D.
Independent Director
Independent Director
--
--
Mr. John J. Kirby
Mr. John J. Kirby
Interim Chief Financial Officer, Interim Principal Financial Officer
Interim Chief Financial Officer, Interim Principal Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jayson Rieger
Dr. Jayson Rieger
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
183.30K
+94311.00%
Mr. David Zawitz
Mr. David Zawitz
Chief Operating Officer
Chief Operating Officer
21.00K
+10000.00%
Dr. Noah L. Rosenberg, M.D.
Dr. Noah L. Rosenberg, M.D.
Chief Medical Officer
Chief Medical Officer
2.36K
+2357.00%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Independent Director
Independent Director
10.00
--
Dr. Gavin Corcoran
Dr. Gavin Corcoran
Independent Director
Independent Director
2.00
--
Mr. Paul B. Manning
Mr. Paul B. Manning
Chairman of the Board
Chairman of the Board
--
--
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: sáb, 31 de jan
Atualizado em: sáb, 31 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Manning (Paul B.)
28.51%
BKB Growth Investments LLC
20.94%
Caligan Partners, LP
5.78%
Affinity Asset Advisors LLC
4.42%
Armistice Capital LLC
4.00%
Outro
36.35%
Investidores
Investidores
Proporção
Manning (Paul B.)
28.51%
BKB Growth Investments LLC
20.94%
Caligan Partners, LP
5.78%
Affinity Asset Advisors LLC
4.42%
Armistice Capital LLC
4.00%
Outro
36.35%
Tipos de investidores
Investidores
Proporção
Individual Investor
31.47%
Corporation
21.10%
Hedge Fund
14.84%
Investment Advisor/Hedge Fund
2.43%
Investment Advisor
1.54%
Venture Capital
0.18%
Family Office
0.11%
Research Firm
0.02%
Outro
28.32%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
174
3.04M
19.01%
-494.27K
2025Q3
171
2.46M
26.06%
-1.46M
2025Q2
183
8.91M
96.35%
+3.15M
2025Q1
194
69.94M
75.99%
+19.16M
2024Q4
191
70.39M
77.72%
+35.42M
2024Q3
179
29.67M
67.28%
-5.27M
2024Q2
173
33.68M
79.75%
-1.13M
2024Q1
171
34.51M
82.01%
-2.46M
2023Q4
170
35.04M
83.66%
+1.56M
2023Q3
172
32.74M
78.91%
-2.85M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Manning (Paul B.)
4.56M
28.51%
+1.42M
+45.27%
Nov 25, 2025
BKB Growth Investments LLC
3.35M
20.94%
+2.75M
+460.29%
Nov 25, 2025
Caligan Partners, LP
923.91K
5.78%
--
--
Dec 26, 2025
Affinity Asset Advisors LLC
707.34K
4.42%
+707.34K
--
Nov 25, 2025
Armistice Capital LLC
639.19K
4%
-248.94K
-28.03%
Sep 30, 2025
Boothbay Fund Management, LLC
280.73K
1.76%
+280.73K
--
Sep 30, 2025
Stalfort (John A)
187.38K
1.17%
+23.81K
+14.56%
Apr 01, 2025
Rieger (Jayson)
183.30K
1.15%
+94.31K
+105.98%
Nov 25, 2025
The Vanguard Group, Inc.
225.21K
1.41%
+8.38K
+3.86%
Sep 30, 2025
Millennium Management LLC
71.99K
0.45%
-18.72K
-20.64%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Russell 2000 Growth ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Dimensional US Core Equity 1 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
Avantis US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 ETF
0%
Ver Mais
iShares Micro-Cap ETF
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0%
Dimensional US Core Equity 1 ETF
Proporção0%
Global X Russell 2000 Covered Call ETF
Proporção0%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
Global X Russell 2000 ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Jul 23, 2025
Merger
10→1
Data
Data ex-dividendo
Tipo
Proporção
Jul 23, 2025
Merger
10→1
